<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23056456</article-id><article-id pub-id-type="pmc">3463530</article-id><article-id pub-id-type="publisher-id">PONE-D-12-22087</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0046796</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical Research Design</subject><subj-group><subject>Longitudinal Studies</subject></subj-group></subj-group><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Test Evaluation</subject></subj-group></subj-group><subj-group><subject>Mental Health</subject><subj-group><subject>Psychiatry</subject><subj-group><subject>Mood Disorders</subject></subj-group></subj-group><subj-group><subject>Psychology</subject><subj-group><subject>Behavior</subject><subj-group><subject>Emotions</subject></subj-group></subj-group><subj-group><subject>Clinical Psychology</subject></subj-group></subj-group></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Health Screening</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Social and Behavioral Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Clinical Psychology</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Can a One-Item Mood Scale Do the Trick? Predicting Relapse over 5.5-Years in Recurrent Depression</article-title><alt-title alt-title-type="running-head">Can a One-Item Mood Scale Do the Trick?</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>van Rijsbergen</surname><given-names>Gerard D.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bockting</surname><given-names>Claudi L. H.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Berking</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Koeter</surname><given-names>Maarten W. J.</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Schene</surname><given-names>Aart H.</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Clinical Psychology and Psychotherapy, University of Marburg, Marburg, Germany</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Baune</surname><given-names>Bernhard T.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Adelaide, Australia</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>c.l.h.bockting@rug.nl</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: CB AS. Performed the experiments: CB. Analyzed the data: GR CB. Wrote the paper: GR CB MB MK AS.</p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>3</day><month>10</month><year>2012</year></pub-date><volume>7</volume><issue>10</issue><elocation-id>e46796</elocation-id><history><date date-type="received"><day>26</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>6</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; 2012 van Rijsbergen et al</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>van Rijsbergen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>To examine whether a simple Visual Analogue Mood Scale (VAMS) is able to predict time to relapse over 5.5-years.</p></sec><sec><title>Methodology/Principal Findings</title><p>187 remitted recurrently depressed out-patients were interviewed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the 17-item Hamilton Depression rating scale (HAM-D) to verify remission status (HAM-D &#x0003c;10). All patients rated their current mood with the help of a Visual Analogue Mood Scale (VAMS) at baseline and at a follow-up assessment three months later. Relapse over 5.5-years was assessed by the SCID-I. Cox regression revealed that both the VAMS at baseline and three months later significantly predicted time to relapse over 5.5-years. Baseline VAMS even predicted time to relapse when the number of previous depressive episodes and HAM-D scores were controlled for. The baseline VAMS explained 6.3% of variance in time to relapse, comparable to the HAM-D interview.</p></sec><sec><title>Conclusions/Significance</title><p>Sad mood after remission appears to play a pivotal role in the course of depression. Since a simple VAMS predicted time to relapse, the VAMS might be an easy and time-effective way to monitor mood and risk of early relapse, and offers possibilities for daily monitoring using e-mail and SMS.</p></sec><sec><title>Trial Registration</title><p>International Standard Randomized Controlled Trial Register Identifier: <ext-link ext-link-type="uri" xlink:href="http://www.controlled-trials.com/ISRCTN68246470/ISRCTN68246470">ISRCTN68246470</ext-link>.</p></sec></abstract><funding-group><funding-statement>This research is funded by ZONMW: The Netherlands Association for Health research and Development (ZONMW, prevention: 2200.0029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="5"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Major Depressive Disorder (MDD) is a recurrent disorder with 80% risk of relapse in the absence of adequate treatment <xref rid="pone.0046796-Mueller1" ref-type="bibr">[1]</xref>. After remission, residual symptoms are a consistent predictor of relapse <xref rid="pone.0046796-Paykel1" ref-type="bibr">[2]</xref>, <xref rid="pone.0046796-Judd1" ref-type="bibr">[3]</xref>. Since residual symptoms are known to fluctuate within patients <xref rid="pone.0046796-Judd2" ref-type="bibr">[4]</xref>, thorough and frequent monitoring after remission is important in order to detect potential relapse.</p><p>The semi-structured Hamilton Depression rating scale (HAM-D) interview <xref rid="pone.0046796-Hamilton1" ref-type="bibr">[5]</xref> is one of the most frequently used instruments to monitor patients and assess depressive symptomatology <xref rid="pone.0046796-Williams1" ref-type="bibr">[6]</xref>. Higher scores on the HAM-D have been found to predict relapse <xref rid="pone.0046796-Kennedy1" ref-type="bibr">[7]</xref>&#x02013;<xref rid="pone.0046796-TenDoesschate1" ref-type="bibr">[10]</xref>. Nevertheless, administration of the HAM-D has some disadvantages including its extensive length (similar to self-report measures; IDS-SR: 30 items, BDI-II: 21 items), time required for administration, and reliance on training <xref rid="pone.0046796-Hooijer1" ref-type="bibr">[11]</xref>, <xref rid="pone.0046796-Engelhardt1" ref-type="bibr">[12]</xref>. Unidimensional subscales (six up to 14 items) derived from the HAM-D were comparable to the total HAM-D in predicting which patients had remitted from acute MDD <xref rid="pone.0046796-Maier1" ref-type="bibr">[13]</xref>&#x02013;<xref rid="pone.0046796-Ruh1" ref-type="bibr">[18]</xref>. However, even less extensive versions of the HAM-D are time consuming and rely on training.</p><p>Depressed mood after remission appears to be an important symptom in the process of relapse. A recent study demonstrated that depressed mood after remission, as assessed by the Mood Spectrum Self-report Questionnaire, was predictive of relapse over 6 months in remitted patients <xref rid="pone.0046796-Rucci1" ref-type="bibr">[19]</xref>. Moreover, mood reactivity to a sad mood provocation (i.e. increases in sad mood) was a vulnerability factor in 48 remitted depressed patients <xref rid="pone.0046796-Lethbridge1" ref-type="bibr">[20]</xref>, and predicted relapse over 5.5-years prospectively in 172 remitted recurrently depressed patients <xref rid="pone.0046796-Van1" ref-type="bibr">[21]</xref>. Depressed mood is also among the symptoms experienced in both the prodromal and the residual phase of depression <xref rid="pone.0046796-Iacoviello1" ref-type="bibr">[22]</xref>. This finding provides empirical support for the rollback theory in which residual symptoms are considered prodromal symptoms for the next depressive episode <xref rid="pone.0046796-Iacoviello1" ref-type="bibr">[22]</xref>&#x02013;<xref rid="pone.0046796-Fava2" ref-type="bibr">[24]</xref>.</p><p>Mood can be assessed within one minute with a simple Visual Analogue Mood Scale (VAMS), on which patients rate their current mood by placing a single mark on a simple 10-centimeter line with &#x02018;happy&#x02019; and &#x02018;sad&#x02019; on either side. Indication of current mood using a 10-centimeter black line was found to correlate with HAM-D (<italic>r</italic>&#x0200a;=&#x0200a;.79; anchors &#x02018;normal&#x02019; to &#x02018;most depressed&#x02019;) and BDI (<italic>r</italic>&#x0200a;=&#x0200a;.58; anchors &#x02018;not at all depressed&#x02019; to &#x02018;most depressed&#x02019;) scores and was also able to detect clinical change <xref rid="pone.0046796-Little1" ref-type="bibr">[25]</xref>&#x02013;<xref rid="pone.0046796-Zealley1" ref-type="bibr">[30]</xref>. Benefits of a VAMS include the limited amount of time and absence of clinical training required, easy comprehensibility, and easy application throughout daily life of a high risk patient. Moreover, the VAMS offers opportunities for mood monitoring via internet and text messages. We are unaware of any studies using a VAMS in the prediction of relapse in depression.</p><p>Therefore the current study is the first to examine a) whether a VAMS predicts time to relapse in depression over 5.5-years in patients currently in remission from MDD, and b) the amount of variance explained in predicting time to relapse by the VAMS alone as well as c) when added to the HAM-D interview and vice versa.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Participants</title><p>The current study was part of a Randomized Controlled Trial comparing the effectiveness of preventive Cognitive Therapy (CT) added to Treatment As Usual (TAU) and compared to TAU alone in the prevention of relapse. The protocol was approved by the Amsterdam Medical Center ethical board. All patients provided written informed consent prior to participation in the study (see <xref rid="pone.0046796-Bockting2" ref-type="bibr">[31]</xref>, <xref rid="pone.0046796-Bockting3" ref-type="bibr">[32]</xref> for more details). All participants of the RCT participated in the current study. In order to participate in the study patients had a) experienced two or more Major Depressive Episodes (MDEs) in the previous five years and b) current remission of MDE for at least 10 weeks but no longer than two years both defined according to the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (DSM&#x02013;IV, <xref rid="pone.0046796-AmericanPsychological1" ref-type="bibr">[33]</xref>) and assessed with the Structured Clinical Interview for DSM&#x02013;IV (SCID, <xref rid="pone.0046796-Spitzer1" ref-type="bibr">[34]</xref>) administered by trained interviewers; and c) a current score of &#x0003c;10 on the HAM-D. Exclusion criteria were: current mania or hypomania or a history of bipolar illness, any psychotic disorder (current and previous), organic brain damage, alcohol or drug abuse, predominant anxiety disorder, recent electroconvulsion therapy, recent cognitive treatment or receiving CT at the start of the study, or current psychotherapy with a frequency of more than twice a month.</p></sec><sec id="s2b"><title>Measures</title><sec id="s2b1"><title>Visual analogue mood scale</title><p>Patients were asked to rate their current mood at baseline and three months after baseline by placing a cross on a Visual Analogue Mood Scale (VAMS) with the following instruction: &#x02018;You can answer the following question by placing a cross on the line from 0 to 10: at the moment I feel.&#x02019;. The VAMS measured 100 mm between the two anchors with the descriptor &#x0201c;happy&#x0201d; located to the left of the center while &#x0201c;sad&#x0201d; was located on the right.</p></sec></sec><sec id="s2c"><title>17-item Hamilton Depression Rating Scale</title><p>The 17-item Hamilton Depression rating scale (HAM-D, <xref rid="pone.0046796-Hamilton1" ref-type="bibr">[5]</xref>) was used by telephone <xref rid="pone.0046796-Simon1" ref-type="bibr">[35]</xref> to assess levels of depressive symptomatology at baseline and three months after baseline. This widely used semi-structured interview covers affective, behavioral and biological symptoms with scores that range between 0 and 52. The HAM-D was administered by trained research assistants and psychologists who were blind to treatment condition. Second ratings (<italic>n</italic>&#x0200a;=&#x0200a;17) demonstrated high intraclass correlation (<italic>r&#x0200a;=&#x0200a;</italic>.94), indicating high agreement.</p></sec><sec id="s2d"><title>Relapse/recurrence</title><p>The main outcome measure was time to relapse/recurrence assessed using the SCID-I. Current and past MDEs were checked for all patients at five assessment-points (3, 12, 24, 36 and 66 months). To keep the assessors blind with respect to treatment condition, we instructed participants not to reveal this information to the interviewers. Kappa (&#x003ba;) for interrater agreement on relapse between the interviewers and an independent psychiatrist, assessed over the assessment period, ranged between 0.94 to 0.96, indicating excellent agreement.</p></sec><sec id="s2e"><title>Use of Antidepressant Medication (ADM)</title><p>Patients were asked about their use of ADM for the last depression before entry of the study and whether they continued using ADM after remission <xref rid="pone.0046796-Bockting4" ref-type="bibr">[36]</xref>, <xref rid="pone.0046796-TenDoesschate2" ref-type="bibr">[37]</xref>. During the first two years of the study, every three months, information on ADM (type and dosage) over the previous month was monitored using the Trimbos/iMTA Self-Report Questionnaire for Costs associated with Psychiatric Illness <xref rid="pone.0046796-HakkaartvanRoijen1" ref-type="bibr">[38]</xref>, which covers a maximum recall period of one month. Additionally, information on continuous use was also collected by the interviewer during the 24, 36 and 66 month interviews retrospectively. Adherence was assessed with the Medication Adherence Questionnaire (MAQ) <xref rid="pone.0046796-Morisky1" ref-type="bibr">[39]</xref>.</p></sec><sec id="s2f"><title>Statistical Analysis</title><p>First of all, we were interested in the prediction of time to relapse within 5.5-years by the VAMS at the two available assessment-points (baseline and three months after baseline). We used survival analysis (Cox regression) in which patients who dropped-out or who did not relapse within 5.5-years were treated as censored. Since use of ADM and number of previous episodes might influence VAMS scores, we checked all models for confounding by these variables.</p><p>To assess whether CT moderated the relation between the predictors and relapse, we examined the two-way interaction of Condition x predictor and the three-way interaction of Condition x predictor x Previous MDEs since in a previous study the number of previous MDEs was a moderator of predictors of interest on relapse <xref rid="pone.0046796-Bockting2" ref-type="bibr">[31]</xref>, <xref rid="pone.0046796-Bockting3" ref-type="bibr">[32]</xref>. If CT affected this relation the analyses was restricted to the control group only, otherwise the analysis was performed on the complete sample.</p><p>Moreover, we were interested in the amount of variance explained in time to relapse by the VAMS and the HAM-D interview. Since Cox regression does not provide a measure for explained variance directly, we calculated explained variance using Nagelkerke&#x02019;s R<sup>2</sup>
<xref rid="pone.0046796-Nagelkerke1" ref-type="bibr">[40]</xref> formula. We calculated explained variance for a model containing the VAMS only, as well as two combined models in which the HAM-D was entered in the first block whereas the VAMS was entered in the second block and vice versa.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Patient Characteristics and Flow</title><p>In total 187 formerly depressed patients were included in the study. For the analyses we excluded 15 patients (drop-outs), resulting in a remaining 172 patients. Drop-outs were slightly younger (<italic>t</italic>(170)&#x0200a;=&#x0200a;&#x02212;2.25, <italic>p</italic>&#x0200a;=&#x0200a;0.03), but did not differ on any other characteristic.</p><p>Demographic and clinical characteristics are summarized in <xref ref-type="table" rid="pone-0046796-t001">Table 1</xref>. Patients were predominantly female (74%) and were currently in remission of a highly recurrent MDD (median number of MDEs: 4.0) with 3.8 residual symptoms (HAM-D) on average.</p><table-wrap id="pone-0046796-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0046796.t001</object-id><label>Table 1</label><caption><title>Demographic and Clinical Characteristics at Baseline.</title></caption><alternatives><graphic id="pone-0046796-t001-1" xlink:href="pone.0046796.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TAU (n&#x0200a;=&#x0200a;84)</td><td align="left" rowspan="1" colspan="1">TAU + CT (n&#x0200a;=&#x0200a;88)</td></tr></thead><tbody><tr><td colspan="3" align="left" rowspan="1">Demographics<xref ref-type="table-fn" rid="nt102">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Female % (n)</td><td align="left" rowspan="1" colspan="1">74.0 (62)</td><td align="left" rowspan="1" colspan="1">73.0 (64)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">43.4 (9.8)</td><td align="left" rowspan="1" colspan="1">45.9 (9.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Median previous episodes (IQR)</td><td align="left" rowspan="1" colspan="1">3.0 (3.8)</td><td align="left" rowspan="1" colspan="1">4.0 (3.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age of first onset</td><td align="left" rowspan="1" colspan="1">28.1 (12.5)</td><td align="left" rowspan="1" colspan="1">28.9 (12.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Patients on antidepressants% (n)</td><td align="left" rowspan="1" colspan="1">50.0 (42.0)</td><td align="left" rowspan="1" colspan="1">52.0 (46.0)</td></tr><tr><td colspan="3" align="left" rowspan="1">Clinical characteristics</td></tr><tr><td align="left" rowspan="1" colspan="1">VAMS<sub>baseline</sub>
</td><td align="left" rowspan="1" colspan="1">37.0 (21.0)</td><td align="left" rowspan="1" colspan="1">34.0 (20.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">VAMS<sub>three months</sub>
</td><td align="left" rowspan="1" colspan="1">33.0 (19.0)</td><td align="left" rowspan="1" colspan="1">32.0 (18.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total HAM-D<sub>17</sub>
</td><td align="left" rowspan="1" colspan="1">3.7 (2.9)</td><td align="left" rowspan="1" colspan="1">3.8 (2.8)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>
<italic>Note.</italic> TAU&#x0200a;=&#x0200a;Treatment As Usual, CT&#x0200a;=&#x0200a;Cognitive Therapy, IQR&#x0200a;=&#x0200a;Interquartile Range, VAMS&#x0200a;=&#x0200a;Visual Analogue Mood Scale.</p></fn><fn id="nt102"><label>a</label><p>All values represent mean (SD) unless stated otherwise.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Preliminary VAMS Analyses</title><p>The VAMS at baseline and three months later demonstrated moderate stability and were significantly associated (<italic>r</italic>&#x0200a;=&#x0200a;.30; <italic>p</italic>&#x0003c;0.001). After controlling for depressive symptoms (HAM-D) at three months after baseline, both VAMS measurements remained significantly associated (<italic>r</italic>&#x0200a;=&#x0200a;.25; <italic>p</italic>&#x0200a;=&#x0200a;0.001).</p></sec><sec id="s3c"><title>Prediction of Relapse Using the VAMS</title><p>Since none of the interaction terms were significant and neither the number of previous MDEs nor use of ADM confounded the predictor of interest, interaction terms were subsequently dropped from the model and Cox regression was fitted with the individual predictor only (see <xref ref-type="supplementary-material" rid="pone.0046796.s001">Table S1</xref>, <xref ref-type="supplementary-material" rid="pone.0046796.s002">S2</xref> for interaction coefficients).</p><p>Cox regression revealed that the baseline VAMS significantly predicted time to relapse in 5.5-years (Wald &#x003c7; (2,1)&#x0200a;=&#x0200a;11.758, <italic>p&#x0200a;=&#x0200a;</italic>0.001, hazard ratio&#x0200a;=&#x0200a;1.15). Each centimeter increase on the VAMS increased the prospective risk of relapse with a factor 1.15 (15%). The baseline VAMS remained a significant predictor up and above the most consistent predictors of relapse, the total HAM-D and the number of previous MDEs.</p><p>In order to replicate prediction of relapse by a single VAMS in the current sample, we subsequently investigated whether a single VAMS administered three months after baseline was also predictive of relapse. Again, a single VAMS predicted time to relapse in 5.5-years (Wald &#x003c7; (2,1)&#x0200a;=&#x0200a;7.091, <italic>p&#x0200a;=&#x0200a;</italic>0.008, hazard ratio&#x0200a;=&#x0200a;1.12), though this time not up and above the total HAM-D.</p></sec><sec id="s3d"><title>Comparing Explained Variance of the Baseline VAMS to the HAM-D</title><p>A previous study on this sample already demonstrated that the total baseline HAM-D predicted time to relapse, and explained 6.0% in variance of time to relapse over 5.5-years <xref rid="pone.0046796-TenDoesschate1" ref-type="bibr">[10]</xref>.</p><p>We were now interested in the amount of variance explained by the baseline VAMS, which was 6.3% (comparable between conditions, 5.5% for TAU and 6.8% for TAU+CT). Second, when the VAMS was added to a model already containing the HAM-D, explained variance of the model increased from 6.0% to 10.3%. Likewise, when the total HAM-D was added to a model already containing the VAMS, an additional 4.1% was explained.</p></sec></sec><sec id="s4"><title>Discussion</title><p>The current study focused on the question whether a simple Visual Analogue Mood Scale (VAMS) predicted time to relapse in depression over 5.5-years, and how well the VAMS predicted time to relapse compared to the HAM-D.</p><p>The current study demonstrated that even a simple VAMS was able to predict time to relapse for 5.5-years in recurrently depressed patients currently in remission. Both VAMS measurements (at baseline and three months later) predicted time to relapse and were significantly associated to each other. The baseline VAMS even predicted relapse up and above a frequently used depression interview, i.e. the HAM-D interview. Our findings stress the relevance of mood as a risk factor for relapse, which is in line with previous studies <xref rid="pone.0046796-Rucci1" ref-type="bibr">[19]</xref>&#x02013;<xref rid="pone.0046796-Van1" ref-type="bibr">[21]</xref>.</p><p>Moreover, the baseline VAMS predicted time to relapse for 5.5-years comparable to the HAM-D interview in terms of explained variance. When the VAMS was added to the HAM-D, additional variance was explained. However, the same was true when HAM-D was added to the VAMS, suggesting differences in what both instruments measure. Nevertheless, the predictive power of the VAMS as well as the HAM-D was indicative of a small effect size (6% in variance). Potentially, when assessed repeatedly, explained variance of the VAMS might increase.</p><p>Previous use of a Visual Analogue Scale in patients already demonstrated high convergent validity (<italic>r</italic>&#x0200a;=&#x0200a;.85) and test re-test reliability (<italic>r</italic>&#x0200a;=&#x0200a;.96) in the improvement of winter depression in 162 patients receiving light therapy <xref rid="pone.0046796-Lingjrde1" ref-type="bibr">[41]</xref>. Furthermore, a Visual Analogue Scale was also able to detect depressive symptoms among 157 elderly patients with cognitive impairments <xref rid="pone.0046796-Kertzman1" ref-type="bibr">[42]</xref>, but also in patients suffering from somatic illnesses including coronary syndrome <xref rid="pone.0046796-DiBenedetto1" ref-type="bibr">[43]</xref> and diabetes mellitus <xref rid="pone.0046796-MaasvanSchaaijk1" ref-type="bibr">[44]</xref>. The current study extends the use of a VAMS to the prediction of relapse in depression. The VAMS is easily administered in less than a minute and might be a feasible way to assess patients at high risk of relapse in clinical practice. Moreover, the VAMS could be used in combination with the HAM-D in stepwise monitoring, as a tool for early detection of relapse using new devices including mobile phone applications, short message service and e-mail monitoring <xref rid="pone.0046796-Bockting5" ref-type="bibr">[45]</xref>&#x02013;<xref rid="pone.0046796-Johansson2" ref-type="bibr">[48]</xref>. When mood on the VAMS appears to be low, monitoring could be intensified using the HAM-D interview.</p><p>Several limitations of the current study have to be noted. First of all, since Cox regression does not provide explained variance directly, explained variance had to be calculated using Nagelkerke&#x02019;s R<sup>2</sup>
<xref rid="pone.0046796-Nagelkerke1" ref-type="bibr">[40]</xref>. The amount of variance explained should therefore be considered as an estimation. Second, although we checked our analyses for confounding by baseline use of ADM, we cannot completely rule out the potential influence of ADM on prediction by the VAMS later in the study since actual use was monitored only twice (retrospectively) in the final 3.5-years of the study. Third, the three-month stability of the VAMS used in the current study was maximal moderate. The use of this simple and quick screening instrument might thus result in decreases in reliability. Finally, lack of standardization of the VAMS has resulted in many different one-item mood scales. While in the current study, similar to previous studies <xref rid="pone.0046796-Segal1" ref-type="bibr">[49]</xref>&#x02013;<xref rid="pone.0046796-Kuyken1" ref-type="bibr">[51]</xref>, &#x02018;happy&#x02019; and &#x02018;sad&#x02019; were used as anchors, other anchors have been described in the literature as well, i.e. &#x02018;neutral&#x02019; to &#x02018;sad&#x02019;, &#x02018;not at all depressed&#x02019; to &#x02018;most depressed&#x02019;, &#x02018;worst mood&#x02019; to &#x02018;best mood&#x02019; <xref rid="pone.0046796-Luria1" ref-type="bibr">[26]</xref>&#x02013;<xref rid="pone.0046796-Cella1" ref-type="bibr">[28]</xref>, <xref rid="pone.0046796-Nyenhuis1" ref-type="bibr">[52]</xref>, which makes it difficult to compare the VAMS among studies and could explain differences in results. It is currently unknown which anchors are most reliable in measuring mood. Future studies should therefore focus on optimizing the VAMS scale by determining the most sensitive and reliable anchor points. Furthermore, since previous studies indicate that mood and fluctuations in mood are related to relapse <xref rid="pone.0046796-Rucci1" ref-type="bibr">[19]</xref>&#x02013;<xref rid="pone.0046796-Van1" ref-type="bibr">[21]</xref> studies should include repeated assessment of mood (daily sampling) to study the stability of mood and thereby enhance early detection of relapse.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0046796.s001"><label>Table S1</label><caption><p>
<bold>Cox Regression Model on Prediction of Relapse Including Three-way Interaction of Predictor x Condition x Previous MDEs (n&#x0200a;=&#x0200a;172).</bold>
</p><p>(DOCX)</p></caption><media xlink:href="pone.0046796.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0046796.s002"><label>Table S2</label><caption><p>
<bold>Cox Regression Model on Prediction of Relapse Including Two-way Interaction of Predictor x Condition (n&#x0200a;=&#x0200a;172).</bold>
</p><p>(DOCX)</p></caption><media xlink:href="pone.0046796.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are most grateful to the patients of our study. In addition, we express our appreciation to the participating psychiatric sites for their recruitment efforts, and to the following therapists for conducting the cognitive therapy: Willemijn Scholten, Swanny Wierenga, Mieke van der Rijken, Ruud Kol, Birgitta Schalken, Els Loeb, Vera van der Kraan, and Annemarie Fouwels. We also thank our interviewers and independent raters and specifically Irene Visch for assistance with data management and support. The following colleagues contributed to the DELTA (Depression Evaluation Longitudinal Therapy Assessment) study: Hanneke Assies, Claudi Bockting, Mascha ten Doesschate, Jochanan Huyser, Anja Lok, Maarten Koeter, Guido Nabarro, Henricus Ruh&#x000e9;, Aart Schene, Philip Spinhoven, Ieke Visser, Ellie Wekking, and Luuk Wouters.</p></ack><ref-list><title>References</title><ref id="pone.0046796-Mueller1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Mueller</surname><given-names>TI</given-names></name>, <name><surname>Leon</surname><given-names>AC</given-names></name> (<year>1999</year>) <article-title>Recurrence after recovery from major depressive disorder during 15 years of observational follow-up</article-title>. <source>American Journal of Psychiatry</source>
<volume>156</volume>: <fpage>1000</fpage>.<pub-id pub-id-type="pmid">10401442</pub-id></mixed-citation></ref><ref id="pone.0046796-Paykel1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Paykel</surname><given-names>ES</given-names></name>, <name><surname>Ramana</surname><given-names>R</given-names></name>, <name><surname>Cooper</surname><given-names>Z</given-names></name>, <name><surname>Hayhurst</surname><given-names>H</given-names></name> (<year>1995</year>) <article-title>Residual symptoms after partial remission: An important outcome in depression</article-title>. <source>Psychological Medicine: A Journal of Research in Psychiatry and the Allied Sciences</source>
<volume>25</volume>: <fpage>1171</fpage>&#x02013;<lpage>1180</lpage>.</mixed-citation></ref><ref id="pone.0046796-Judd1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Judd</surname><given-names>LL</given-names></name>, <name><surname>Akiskal</surname><given-names>HS</given-names></name>, <name><surname>Maser</surname><given-names>JD</given-names></name>, <name><surname>Zeller</surname><given-names>PJ</given-names></name>, <name><surname>Endicott</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse</article-title>. <source>Journal of Affective Disorders</source>
<volume>50</volume>: <fpage>97</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">9858069</pub-id></mixed-citation></ref><ref id="pone.0046796-Judd2"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Judd</surname><given-names>LL</given-names></name>, <name><surname>Akiskal</surname><given-names>HS</given-names></name>, <name><surname>Maser</surname><given-names>JD</given-names></name>, <name><surname>Zeller</surname><given-names>PJ</given-names></name>, <name><surname>Endicott</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders</article-title>. <source>Archives of General Psychiatry</source>
<volume>55</volume>: <fpage>694</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">9707379</pub-id></mixed-citation></ref><ref id="pone.0046796-Hamilton1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Hamilton</surname><given-names>M</given-names></name> (<year>1960</year>) <article-title>A rating scale for depression</article-title>. <source>Journal of Neurology, Neurosurgery, and Psychiatry</source>
<volume>23</volume>: <fpage>56</fpage>&#x02013;<lpage>62</lpage>.</mixed-citation></ref><ref id="pone.0046796-Williams1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Williams</surname><given-names>JBW</given-names></name> (<year>2001</year>) <article-title>Standardizing the hamilton depression rating scale: Past, present, and future</article-title>. <source>European Archives of Psychiatry and Clinical Neuroscience</source>
<volume>251</volume>: <fpage>6</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">11315519</pub-id></mixed-citation></ref><ref id="pone.0046796-Kennedy1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Kennedy</surname><given-names>N</given-names></name>, <name><surname>Paykel</surname><given-names>ES</given-names></name> (<year>2004</year>) <article-title>Residual symptoms at remission from depression: Impact on long-term outcome</article-title>. <source>Journal of Affective Disorders</source>
<volume>80</volume>: <fpage>135</fpage>&#x02013;<lpage>144</lpage>.<pub-id pub-id-type="pmid">15207926</pub-id></mixed-citation></ref><ref id="pone.0046796-Taylor1"><label>8</label><mixed-citation publication-type="other">Taylor DJ, Walters HM, Vittengl JR, Krebaum S, Jarrett RB (2009) Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence? Journal of Affective Disorders.</mixed-citation></ref><ref id="pone.0046796-Bockting1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Bockting</surname><given-names>CLH</given-names></name>, <name><surname>Spinhoven</surname><given-names>P</given-names></name>, <name><surname>Koeter</surname><given-names>MWJ</given-names></name>, <name><surname>Wouters</surname><given-names>LF</given-names></name>, <name><surname>Schene</surname><given-names>AH</given-names></name> (<year>2006</year>) <article-title>Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: A 2-year prospective study</article-title>. <source>Journal of Clinical Psychiatry</source>
<volume>67</volume>: <fpage>747</fpage>&#x02013;<lpage>755</lpage>.<pub-id pub-id-type="pmid">16841624</pub-id></mixed-citation></ref><ref id="pone.0046796-TenDoesschate1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Ten Doesschate</surname><given-names>MC</given-names></name>, <name><surname>Bockting</surname><given-names>CLH</given-names></name>, <name><surname>Koeter</surname><given-names>MWJ</given-names></name>, <name><surname>Schene</surname><given-names>AH</given-names></name> (<year>2010</year>) <article-title>Prediction of recurrence in recurrent depression: A 5.5-year prospective study</article-title>. <source>Journal of Clinical Psychiatry</source>
<volume>71</volume>: <fpage>984</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">20797379</pub-id></mixed-citation></ref><ref id="pone.0046796-Hooijer1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Hooijer</surname><given-names>C</given-names></name>, <name><surname>Zitman</surname><given-names>FG</given-names></name>, <name><surname>Griez</surname><given-names>E</given-names></name>, <name><surname>Van Tilburg</surname><given-names>W</given-names></name> (<year>1991</year>) <article-title>The hamilton depression rating scale (HDRS): Changes in scores as a function of training and version used</article-title>. <source>Journal of Affective Disorders</source>
<volume>22</volume>: <fpage>21</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">1880305</pub-id></mixed-citation></ref><ref id="pone.0046796-Engelhardt1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Engelhardt</surname><given-names>N</given-names></name>, <name><surname>Feiger</surname><given-names>AD</given-names></name>, <name><surname>Cogger</surname><given-names>KO</given-names></name>, <name><surname>Sikich</surname><given-names>D</given-names></name>, <name><surname>DeBrota</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Rating the raters: Assessing the quality of hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trials</article-title>. <source>Journal of Clinical Psychopharmacology</source>
<volume>26</volume>: <fpage>71</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">16415710</pub-id></mixed-citation></ref><ref id="pone.0046796-Maier1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Maier</surname><given-names>W</given-names></name>, <name><surname>Philipp</surname><given-names>M</given-names></name> (<year>1985</year>) <article-title>Comparative analysis of observer depression scales</article-title>. <source>Acta Psychiatrica Scandinavica</source>
<volume>72</volume>: <fpage>239</fpage>&#x02013;<lpage>245</lpage>.<pub-id pub-id-type="pmid">4072721</pub-id></mixed-citation></ref><ref id="pone.0046796-Bech1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Bech</surname><given-names>P</given-names></name> (<year>1981</year>) <article-title>The hamilton depression scale: Evaluation of objectivity using logistic models</article-title>. <source>Acta Psychiatrica Scandinavica</source>
<volume>63</volume>: <fpage>290</fpage>&#x02013;<lpage>299</lpage>.<pub-id pub-id-type="pmid">7015793</pub-id></mixed-citation></ref><ref id="pone.0046796-Bech2"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Bech</surname><given-names>P</given-names></name> (<year>1975</year>) <article-title>Quantitative rating of depressive states: Correlation between clinical assessment, beck&#x02019;s self-rating scale and hamilton&#x02019;s objective rating scale</article-title>. <source>Acta Psychiatrica Scandinavica</source>
<volume>51</volume>: <fpage>161</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">1136841</pub-id></mixed-citation></ref><ref id="pone.0046796-Bech3"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Bech</surname><given-names>P</given-names></name>, <name><surname>Allerup</surname><given-names>P</given-names></name>, <name><surname>Reisby</surname><given-names>N</given-names></name>, <name><surname>Gram</surname><given-names>LF</given-names></name> (<year>1984</year>) <article-title>Assessment of symptom change from improvement curves on the hamilton depression scale in trials with antidepressants</article-title>. <source>Psychopharmacology</source>
<volume>84</volume>: <fpage>276</fpage>&#x02013;<lpage>281</lpage>.<pub-id pub-id-type="pmid">6438690</pub-id></mixed-citation></ref><ref id="pone.0046796-Entsuah1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Entsuah</surname><given-names>R</given-names></name>, <name><surname>Shaffer</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name> (<year>2002</year>) <article-title>A critical examination of the sensitivity of unidimensional subscales derived from the hamilton depression rating scale to antidepressant drug effects</article-title>. <source>Journal of Psychiatric Research</source>
<volume>36</volume>: <fpage>437</fpage>&#x02013;<lpage>448</lpage>.<pub-id pub-id-type="pmid">12393314</pub-id></mixed-citation></ref><ref id="pone.0046796-Ruh1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Ruh&#x000e9;</surname><given-names>HG</given-names></name>, <name><surname>Dekker</surname><given-names>JJ</given-names></name>, <name><surname>Peen</surname><given-names>J</given-names></name>, <name><surname>Holman</surname><given-names>R</given-names></name>, <name><surname>De Jonghe</surname><given-names>F</given-names></name> (<year>2005</year>) <article-title>Clinical use of the hamilton depression rating scale: Is increased efficiency possible? A post hoc comparison of hamilton depression rating scale, maier and bech subscales, clinical global impression, and symptom checklist-90 scores</article-title>. <source>Comprehensive Psychiatry</source>
<volume>46</volume>: <fpage>417</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">16275208</pub-id></mixed-citation></ref><ref id="pone.0046796-Rucci1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Rucci</surname><given-names>P</given-names></name>, <name><surname>Frank</surname><given-names>E</given-names></name>, <name><surname>Calugi</surname><given-names>S</given-names></name>, <name><surname>Miniati</surname><given-names>M</given-names></name>, <name><surname>Benvenuti</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination</article-title>. <source>Depression and Anxiety</source>
<volume>28</volume>: <fpage>955</fpage>&#x02013;<lpage>962</lpage>.<pub-id pub-id-type="pmid">21898715</pub-id></mixed-citation></ref><ref id="pone.0046796-Lethbridge1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Lethbridge</surname><given-names>R</given-names></name>, <name><surname>Allen</surname><given-names>NB</given-names></name> (<year>2008</year>) <article-title>Mood induced cognitive and emotional reactivity, life stress, and the prediction of depressive relapse</article-title>. <source>Behaviour Research &#x00026; Therapy</source>
<volume>46</volume>: <fpage>1142</fpage>&#x02013;<lpage>1150</lpage>.<pub-id pub-id-type="pmid">18707676</pub-id></mixed-citation></ref><ref id="pone.0046796-Van1"><label>21</label><mixed-citation publication-type="other">Van Rijsbergen GD, Bockting CLH, Burger H, Spinhoven P, Koeter MWJ, et al. (In Press). Mood reactivity rather than cognitive reactivity is predictive of depressive recurrence: A randomized study with 5.5-year follow-up.</mixed-citation></ref><ref id="pone.0046796-Iacoviello1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Iacoviello</surname><given-names>BM</given-names></name>, <name><surname>Alloy</surname><given-names>LB</given-names></name>, <name><surname>Abramson</surname><given-names>LY</given-names></name>, <name><surname>Choi</surname><given-names>JY</given-names></name> (<year>2010</year>) <article-title>The early course of depression: A longitudinal investigation of prodromal symptoms and their relation to the symptomatic course of depressive episodes</article-title>. <source>Journal of Abnormal Psychology</source>
<volume>119</volume>: <fpage>459</fpage>&#x02013;<lpage>467</lpage>.<pub-id pub-id-type="pmid">20677835</pub-id></mixed-citation></ref><ref id="pone.0046796-Fava1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Fava</surname><given-names>GA</given-names></name>, <name><surname>Grandi</surname><given-names>S</given-names></name>, <name><surname>Canestrari</surname><given-names>R</given-names></name>, <name><surname>Molnar</surname><given-names>G</given-names></name> (<year>1990</year>) <article-title>Prodromal symptoms in primary major depressive disorder</article-title>. <source>Journal of Affective Disorders</source>
<volume>19</volume>: <fpage>149</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">2142701</pub-id></mixed-citation></ref><ref id="pone.0046796-Fava2"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Fava</surname><given-names>GA</given-names></name>, <name><surname>Grandi</surname><given-names>S</given-names></name>, <name><surname>Zielezny</surname><given-names>M</given-names></name>, <name><surname>Canestrari</surname><given-names>R</given-names></name> (<year>1994</year>) <article-title>Cognitive behavioral treatment of residual symptoms in primary major depressive disorder</article-title>. <source>The American Journal of Psychiatry</source>
<volume>151</volume>: <fpage>1295</fpage>&#x02013;<lpage>1299</lpage>.<pub-id pub-id-type="pmid">8067483</pub-id></mixed-citation></ref><ref id="pone.0046796-Little1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Little</surname><given-names>JC</given-names></name>, <name><surname>McPhail</surname><given-names>NI</given-names></name> (<year>1973</year>) <article-title>Measures of depressive mood at monthly intervals</article-title>. <source>British Journal of Psychiatry</source>
<volume>122</volume>: <fpage>447</fpage>&#x02013;<lpage>452</lpage>.<pub-id pub-id-type="pmid">4718280</pub-id></mixed-citation></ref><ref id="pone.0046796-Luria1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Luria</surname><given-names>RE</given-names></name> (<year>1975</year>) <article-title>The validity and reliability of the visual analogue mood scale</article-title>. <source>Journal of Psychiatric Research</source>
<volume>12</volume>: <fpage>51</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">806683</pub-id></mixed-citation></ref><ref id="pone.0046796-Ahearn1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Ahearn</surname><given-names>EP</given-names></name> (<year>1997</year>) <article-title>The use of visual analog scales in mood disorders: A critical review</article-title>. <source>Journal of Psychiatric Research</source>
<volume>31</volume>: <fpage>569</fpage>&#x02013;<lpage>579</lpage>.<pub-id pub-id-type="pmid">9368198</pub-id></mixed-citation></ref><ref id="pone.0046796-Cella1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Cella</surname><given-names>DF</given-names></name>, <name><surname>Perry</surname><given-names>SW</given-names></name> (<year>1986</year>) <article-title>Reliability and concurrent validity of three visual-analogue mood scales</article-title>. <source>Psychological Reports</source>
<volume>59</volume>: <fpage>827</fpage>&#x02013;<lpage>833</lpage>.<pub-id pub-id-type="pmid">3809343</pub-id></mixed-citation></ref><ref id="pone.0046796-Killgore1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Killgore</surname><given-names>WDS</given-names></name> (<year>1999</year>) <article-title>The visual analogue mood scale: Can a single-item scale accurately classify depressive mood state</article-title>? <source>Psychological Reports</source>
<volume>85</volume>: <fpage>1238</fpage>&#x02013;<lpage>1243</lpage>.<pub-id pub-id-type="pmid">10710979</pub-id></mixed-citation></ref><ref id="pone.0046796-Zealley1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Zealley</surname><given-names>AK</given-names></name>, <name><surname>Aitken</surname><given-names>RC</given-names></name> (<year>1969</year>) <article-title>Measurement of mood</article-title>. <source>Proceedings of the Royal Society of Medicine</source>
<volume>62</volume>: <fpage>993</fpage>&#x02013;<lpage>996</lpage>.<pub-id pub-id-type="pmid">5346176</pub-id></mixed-citation></ref><ref id="pone.0046796-Bockting2"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Bockting</surname><given-names>CLH</given-names></name>, <name><surname>Schene</surname><given-names>AH</given-names></name>, <name><surname>Spinhoven</surname><given-names>P</given-names></name>, <name><surname>Koeter</surname><given-names>MWJ</given-names></name>, <name><surname>Wouters</surname><given-names>LF</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Preventing Relapse/Recurrence in recurrent depression with cognitive therapy: A randomized controlled trial</article-title>. <source>Journal of Consulting &#x00026; Clinical Psychology</source>
<volume>73</volume>: <fpage>647</fpage>&#x02013;<lpage>657</lpage>.<pub-id pub-id-type="pmid">16173852</pub-id></mixed-citation></ref><ref id="pone.0046796-Bockting3"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Bockting</surname><given-names>CLH</given-names></name>, <name><surname>Spinhoven</surname><given-names>P</given-names></name>, <name><surname>Wouters</surname><given-names>LF</given-names></name>, <name><surname>Koeter</surname><given-names>MWJ</given-names></name>, <name><surname>Schene</surname><given-names>AH</given-names></name> (<year>2009</year>) <article-title>Long-term effects of preventive cognitive therapy in recurrent depression: A 5.5-year follow-up study</article-title>. <source>J Clin Psychiatry</source>
<volume>70</volume>: <fpage>1621</fpage>&#x02013;<lpage>1628</lpage>.<pub-id pub-id-type="pmid">20141705</pub-id></mixed-citation></ref><ref id="pone.0046796-AmericanPsychological1"><label>33</label><mixed-citation publication-type="other">American Psychological Association (1994) Diagnostic and statistical manual of mental disorders (4th ed.). Arlington, VA US: American Psychiatric Publishing, Inc.</mixed-citation></ref><ref id="pone.0046796-Spitzer1"><label>34</label><mixed-citation publication-type="other">Spitzer RL, Williams JBW, Gibbon M, First MB (1990) User&#x02019;s guide for the structured clinical interview for DSM-III-R: SCID. Washington, DC US: American Psychiatric Association.</mixed-citation></ref><ref id="pone.0046796-Simon1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Simon</surname><given-names>GE</given-names></name>, <name><surname>Revicki</surname><given-names>D</given-names></name>, <name><surname>VonKorff</surname><given-names>M</given-names></name> (<year>1993</year>) <article-title>Telephone assessment of depression severity</article-title>. <source>Journal of Psychiatric Research</source>
<volume>27</volume>: <fpage>247</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">8295157</pub-id></mixed-citation></ref><ref id="pone.0046796-Bockting4"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Bockting</surname><given-names>CLH</given-names></name>, <name><surname>Ten Doesschate</surname><given-names>MC</given-names></name>, <name><surname>Spijker</surname><given-names>J</given-names></name>, <name><surname>Spinhoven</surname><given-names>P</given-names></name>, <name><surname>Koeter</surname><given-names>MWJ</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Continuation and maintenance use of antidepressants in recurrent depression</article-title>. <source>Psychotherapy and Psychosomatics</source>
<volume>77</volume>: <fpage>17</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">18087204</pub-id></mixed-citation></ref><ref id="pone.0046796-TenDoesschate2"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Ten Doesschate</surname><given-names>MC</given-names></name>, <name><surname>Bockting</surname><given-names>CLH</given-names></name>, <name><surname>Schene</surname><given-names>AH</given-names></name> (<year>2009</year>) <article-title>Adherence to continuation and maintenance antidepressant use in recurrent depression</article-title>. <source>Journal of Affective Disorders</source>
<volume>115</volume>: <fpage>167</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">18760488</pub-id></mixed-citation></ref><ref id="pone.0046796-HakkaartvanRoijen1"><label>38</label><mixed-citation publication-type="other">Hakkaart-van Roijen L, van Straten A, Donker M, Tiemens B (2002) Manual: Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TiC-P). Rotterdam, The Netherlands: Institute for Medical Technology Assessment.</mixed-citation></ref><ref id="pone.0046796-Morisky1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Morisky</surname><given-names>DE</given-names></name>, <name><surname>Green</surname><given-names>LW</given-names></name>, <name><surname>Levine</surname><given-names>DM</given-names></name> (<year>1986</year>) <article-title>Concurrent and predictive validity of a self-reported measure of medication adherence</article-title>. <source>Medical Care</source>
<volume>24</volume>: <fpage>67</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">3945130</pub-id></mixed-citation></ref><ref id="pone.0046796-Nagelkerke1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Nagelkerke</surname><given-names>NJD</given-names></name> (<year>1991</year>) <article-title>A note on a general definition of the coefficient of determination</article-title>. <source>Biometrika</source>
<volume>78</volume>: <fpage>691</fpage>&#x02013;<lpage>692</lpage>.</mixed-citation></ref><ref id="pone.0046796-Lingjrde1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Lingj&#x000e6;rde</surname><given-names>O</given-names></name>, <name><surname>F&#x000f8;reland</surname><given-names>AR</given-names></name> (<year>1998</year>) <article-title>Direct assessment of improvement in winter depression with a visual analogue scale: High reliability and validity</article-title>. <source>Psychiatry Research</source>
<volume>81</volume>: <fpage>387</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">9925190</pub-id></mixed-citation></ref><ref id="pone.0046796-Kertzman1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Kertzman</surname><given-names>S</given-names></name>, <name><surname>Aladjem</surname><given-names>Z</given-names></name>, <name><surname>Milo</surname><given-names>R</given-names></name>, <name><surname>Ben-Nahum</surname><given-names>Z</given-names></name>, <name><surname>Birger</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The utility of the visual analogue scale for the assessment of depressive mood in cognitively impaired patients</article-title>. <source>International Journal of Geriatric Psychiatry</source>
<volume>19</volume>: <fpage>789</fpage>&#x02013;<lpage>796</lpage>.<pub-id pub-id-type="pmid">15290703</pub-id></mixed-citation></ref><ref id="pone.0046796-DiBenedetto1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Di Benedetto</surname><given-names>M</given-names></name>, <name><surname>Lindner</surname><given-names>H</given-names></name>, <name><surname>Hare</surname><given-names>DL</given-names></name>, <name><surname>Kent</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>A cardiac depression visual analogue scale for the brief and rapid assessment of depression following acute coronary syndromes</article-title>. <source>Journal of Psychosomatic Research</source>
<volume>59</volume>: <fpage>223</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">16223625</pub-id></mixed-citation></ref><ref id="pone.0046796-MaasvanSchaaijk1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Maas-van Schaaijk</surname><given-names>NM</given-names></name>, <name><surname>Odink</surname><given-names>RJ</given-names></name>, <name><surname>Ultee</surname><given-names>K</given-names></name>, <name><surname>van Baar</surname><given-names>AL</given-names></name> (<year>2011</year>) <article-title>Can one question be a useful indicator of psychosocial problems in adolescents with diabetes mellitus</article-title>? <source>Acta Paediatrica</source>
<volume>100</volume>: <fpage>708</fpage>&#x02013;<lpage>711</lpage>.<pub-id pub-id-type="pmid">21244483</pub-id></mixed-citation></ref><ref id="pone.0046796-Bockting5"><label>45</label><mixed-citation publication-type="other">Bockting CLH, Kok GD, van der Kamp, Smit F, van Valen E, <etal>et al</etal>. (2011) Disrupting the rhythm of depression using mobile cognitive therapy for recurrent depression: Randomized controlled trial design and protocol. BMC Psychiatry 11.</mixed-citation></ref><ref id="pone.0046796-Farrer1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Farrer</surname><given-names>L</given-names></name>, <name><surname>Christensen</surname><given-names>H</given-names></name>, <name><surname>Griffiths</surname><given-names>KM</given-names></name>, <name><surname>Mackinnon</surname><given-names>A</given-names></name> (<year>2012</year>) <article-title>Web-based cognitive behavior therapy for depression with and without telephone tracking in a national helpline: Secondary outcomes from a randomized controlled trial</article-title>. <source>Journal of Medical Internet Research</source>
<volume>14</volume>: <fpage>e68</fpage>&#x02013;<lpage>e68</lpage>.<pub-id pub-id-type="pmid">22738715</pub-id></mixed-citation></ref><ref id="pone.0046796-Johansson1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Johansson</surname><given-names>R</given-names></name>, <name><surname>Ekbladh</surname><given-names>S</given-names></name>, <name><surname>Hebert</surname><given-names>A</given-names></name>, <name><surname>Lindstr&#x000f6;m</surname><given-names>M</given-names></name>, <name><surname>M&#x000f6;ller</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Psychodynamic guided self-help for adult depression through the internet: A randomised controlled trial</article-title>. <source>Plos One</source>
<volume>7</volume>: <fpage>e38021</fpage>&#x02013;<lpage>e38021</lpage>.<pub-id pub-id-type="pmid">22741027</pub-id></mixed-citation></ref><ref id="pone.0046796-Johansson2"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Johansson</surname><given-names>R</given-names></name>, <name><surname>Sj&#x000f6;berg</surname><given-names>E</given-names></name>, <name><surname>Sj&#x000f6;gren</surname><given-names>M</given-names></name>, <name><surname>Johnsson</surname><given-names>E</given-names></name>, <name><surname>Carlbring</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Tailored vs. standardized internet-based cognitive behavior therapy for depression and comorbid symptoms: A randomized controlled trial</article-title>. <source>Plos One</source>
<volume>7</volume>: <fpage>e36905</fpage>&#x02013;<lpage>e36905</lpage>.<pub-id pub-id-type="pmid">22615841</pub-id></mixed-citation></ref><ref id="pone.0046796-Segal1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Segal</surname><given-names>ZV</given-names></name>, <name><surname>Gemar</surname><given-names>M</given-names></name>, <name><surname>Williams</surname><given-names>S</given-names></name> (<year>1999</year>) <article-title>Differential cognitive response to a mood challenge following successful cognitive therapy or</article-title>. <source>Journal of Abnormal Psychology</source>
<volume>108</volume>: <fpage>3</fpage>.<pub-id pub-id-type="pmid">10066988</pub-id></mixed-citation></ref><ref id="pone.0046796-Segal2"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Segal</surname><given-names>ZV</given-names></name>, <name><surname>Kennedy</surname><given-names>S</given-names></name>, <name><surname>Gemar</surname><given-names>M</given-names></name>, <name><surname>Hood</surname><given-names>K</given-names></name>, <name><surname>Pedersen</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Cognitive reactivity to sad mood provocation and the prediction of depressive relapse</article-title>. <source>Archives of General Psychiatry</source>
<volume>63</volume>: <fpage>749</fpage>&#x02013;<lpage>755</lpage>.<pub-id pub-id-type="pmid">16818864</pub-id></mixed-citation></ref><ref id="pone.0046796-Kuyken1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Kuyken</surname><given-names>W</given-names></name>, <name><surname>Watkins</surname><given-names>E</given-names></name>, <name><surname>Holden</surname><given-names>E</given-names></name>, <name><surname>White</surname><given-names>K</given-names></name>, <name><surname>Taylor</surname><given-names>RS</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>How does mindfulness-based cognitive therapy work</article-title>? <source>Behaviour Research and Therapy</source>
<volume>48</volume>: <fpage>1105</fpage>&#x02013;<lpage>1112</lpage>.<pub-id pub-id-type="pmid">20810101</pub-id></mixed-citation></ref><ref id="pone.0046796-Nyenhuis1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Nyenhuis</surname><given-names>DL</given-names></name>, <name><surname>Stern</surname><given-names>RA</given-names></name>, <name><surname>Yamamoto</surname><given-names>C</given-names></name>, <name><surname>Luchetta</surname><given-names>T</given-names></name>, <name><surname>Arruda</surname><given-names>JE</given-names></name> (<year>1997</year>) <article-title>Standardization and validation of the visual analog mood scales</article-title>. <source>Clinical Neuropsychologist</source>
<volume>11</volume>: <fpage>407</fpage>&#x02013;<lpage>415</lpage>.</mixed-citation></ref></ref-list></back></article>